On Thursday shares of Anika Therapeutics Inc. (NASDAQ:ANIK) closed at $34.12. Company’s sales growth for last 5 years was 21.40% and EPS growth for next 5 years is recorded as 30.00%. Anika Therapeutics, Inc. (NASDAQ:ANIK), announced that seven abstracts related to our Hyalofast product are scheduled for presentation at the 12th Annual World Congress of the International Cartilage Repair Society (ICRS) May 8-11, 2015 at the Sheraton Chicago Hotel & Towers in Chicago, Illinois.
BioSpecifics Technologies Corp. (NASDAQ:BSTC) in last trading activity moved up 1.30% to close at $38.31. Company weekly performance is 0.84% while its quarterly performance stands at -6.45%. BioSpecifics Technologies Corp. (NASDAQ:BSTC) is -8.79% away from its 52 week high. On April 22, BioSpecifics Technologies Corp. (NASDAQ:BSTC), announced the appointment of two new members to its Board of Directors, Ms. Jennifer Chao and Jyrki Mattila , M.D., Ph.D.
On Thursday shares of Visa Inc. (NYSE:V) closed at $66.05. Company’s sales growth for last 5 years was 12.90% and EPS growth for next 5 years is recorded as 18.08%. Visa Inc. (NYSE:V) reported net income for the second quarter was $1.55 billion or $0.63 class A share, compared to $1.60 billion or $0.63 per class A share fo the year-ago quarter.
Gilead Sciences Inc. (NASDAQ:GILD) in last trading activity moved down -1.77% to close at $100.51. Company weekly performance is -4.47% while its quarterly performance stands at -3.52%. Gilead Sciences Inc. (NASDAQ:GILD) is -13.97% away from its 52 week high. Gilead Sciences Inc. (NASDAQ:GILD) on Thursday said its quarterly profit nearly doubled, driven by strong sales of its hepatitis C drugs, as it topped Wall Street estimates. Excluding items, Gilead earned $2.94 per share in the first quarter, beating the average Wall Street estimate of $2.32, according to Thomson Reuters I/B/E/S.
Heartware International Inc. (NASDAQ:HTWR) has 0.70% insider ownership. In last trading activity company’s stock closed at $75.71. On April 30, HeartWare International, Inc. (NASDAQ:HTWR), announced revenue of $70.0 million for the first quarter ended March 31, 2015, a five percent increase compared to $66.5 million in revenue for the same period of 2014. Currency fluctuations negatively impacted total revenue growth by approximately $5 million, or nearly eight percentage points, in the first quarter of 2015, as compared to the same period in 2014.